These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6458353)

  • 1. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
    Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.
    Miyazaki S; Akiyoshi T; Arinaga S; Koba F; Wada T; Tsuji H
    Clin Exp Immunol; 1983 Nov; 54(2):573-9. PubMed ID: 6228356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder.
    Herr HW; Bean MA; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):177-81. PubMed ID: 155221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 8. Bovine monocytes and macrophages: an accessory role in suppressor-cell generation by Con A and in lectin-induced proliferation.
    Ohmann HB; Filion LG; Babiuk LA
    Immunology; 1983 Oct; 50(2):189-97. PubMed ID: 6225726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
    Jones LW; O'Toole C
    Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human urinary bladder carcinoma cell line (T24): immunological studies and search for oncornavirus in T24 cell population and derived clones.
    Bubeník J; Asfahani A; Sherif M; El Ridi R; Mach O; Machácková M; Jandlová T; Símová J; Hanus M; Hradec E; Malkovský M
    Neoplasma; 1978; 25(5):513-22. PubMed ID: 84343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
    Bean MA; Schellhammer PS; Herr HW; Pinsky CM; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):111-4. PubMed ID: 155219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
    Troye M; Pape GR
    Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.
    Kastelan Z; Lukac J; Derezić D; Pasini J; Kusić Z; Sosić H; Kastelan M
    Anticancer Res; 2003; 23(6D):5185-9. PubMed ID: 14981987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cell-mediated cytolytic mechanisms against human transitional cell carcinoma line, 253J.
    Catalona WJ; Ratliff TL; McCool RE
    Immunology; 1980 Jan; 39(1):119-25. PubMed ID: 7380462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular (T cell) immunity in the human newborn.
    Stiehm ER; Winter HS; Bryson YJ
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):814-21. PubMed ID: 159431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte-mediated regulation of cellular immunity in humans: loss of suppressor activity with ageing.
    Becker MJ; Drucker I; Farkas R; Steiner Z; Klajman A
    Clin Exp Immunol; 1981 Aug; 45(2):439-46. PubMed ID: 6976249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.